Software & Developer Tools
21st.BIO
21st.BIO is a Software & Developer Tools startup, most recent round Series C+, 1 tracked investor.
activeseries-c-plus
series-c-plus
Stage
1
Investors
About 21st.BIO
21st.BIO is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Software & Developer Tools. Brouky records 1 investor associated with the company.
21st Solutions develops AmyletiX, a technology that improves delivery and bioavailability of hydrophobic ingredients for pharmaceutical, nutraceutical, cosmetic, food & beverage, and pet care applications.
Explore 21st.BIO's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.